Trials / Conditions / Endometrial Papillary Serous Carcinoma
Endometrial Papillary Serous Carcinoma
4 registered clinical trials studyying Endometrial Papillary Serous Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanc NCT01198184 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Th NCT00416455 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer NCT00072176 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT00025467 | National Cancer Institute (NCI) | Phase 2 |